Viewing Study NCT07455851


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 7:36 AM
Study NCT ID: NCT07455851
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-06
First Post: 2026-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module